Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.33%82.53B | -10.06%61.3B | -9.38%41.29B | -10.67%19.05B | -35.51%91.03B | -31.27%68.15B | -30.44%45.57B | -32.08%21.33B | 6.92%141.16B | 16.21%99.16B |
| Operating income | -9.33%82.53B | -10.06%61.3B | -9.38%41.29B | -10.67%19.05B | -35.51%91.03B | -31.27%68.15B | -30.44%45.57B | -32.08%21.33B | 6.92%141.16B | 16.21%99.16B |
| Cost of sales | 11.99%-63.56B | ---- | 16.03%-31.4B | ---- | 39.18%-72.22B | ---- | 29.80%-37.39B | ---- | -13.27%-118.74B | ---- |
| Operating expenses | 11.99%-63.56B | 15.37%-46.4B | 16.03%-31.4B | 16.25%-14.69B | 39.18%-72.22B | 32.27%-54.83B | 29.80%-37.39B | 33.07%-17.54B | -13.27%-118.74B | -27.13%-80.96B |
| Gross profit | 0.86%18.97B | 11.84%14.89B | 21.05%9.89B | 15.16%4.36B | -16.06%18.81B | -26.81%13.32B | -33.21%8.17B | -27.11%3.79B | -17.57%22.41B | -15.92%18.2B |
| Selling expenses | -2.51%-3.5B | -6.74%-2.49B | -4.51%-1.63B | -4.68%-752.05M | 0.29%-3.42B | 7.96%-2.33B | 3.92%-1.56B | 8.33%-718.42M | -2.95%-3.43B | -9.39%-2.54B |
| Administrative expenses | -0.90%-5.66B | -2.46%-4.39B | -5.64%-2.72B | -2.93%-1.39B | -3.33%-5.61B | 5.52%-4.29B | 10.28%-2.57B | 8.81%-1.35B | -0.86%-5.43B | -18.71%-4.54B |
| Research and development expenses | 32.59%-847.45M | 44.64%-478.83M | 40.55%-308.66M | 5.55%-175.46M | 33.89%-1.26B | 34.02%-865.02M | 29.24%-519.22M | 29.98%-185.76M | 5.46%-1.9B | 8.41%-1.31B |
| Profit from asset sales | ---- | 148.61%4.61M | ---- | 2,352.47%2.87M | ---- | -123.93%-9.47M | ---- | -212.09%-127.42K | ---- | 930.80%39.6M |
| Revaluation surplus | ---- | 214.82%84.91M | ---- | 58.31%-8.74M | ---- | 12.62%-73.95M | ---- | -118.75%-20.96M | ---- | 77.14%-84.63M |
| -Changes in the fair value of other assets | ---- | 214.82%84.91M | ---- | 58.31%-8.74M | ---- | 12.62%-73.95M | ---- | -118.75%-20.96M | ---- | 77.14%-84.63M |
| Impairment and provision | -156.41%-906.99M | -1,534.61%-303.49M | ---296.66M | -116.63%-1.54M | -5.94%-353.73M | 34.88%-18.57M | ---- | 86.15%-710.01K | -21,194.32%-333.9M | 14.15%-28.51M |
| -Other impairment is provision | -156.41%-906.99M | -1,534.61%-303.49M | ---296.66M | -116.63%-1.54M | -5.94%-353.73M | 34.88%-18.57M | ---- | 86.15%-710.01K | -21,194.32%-333.9M | 14.15%-28.51M |
| Special items of operating profit | 0.92%2.72B | 33.80%832.23M | -1.83%1.22B | 43.31%199.2M | -15.04%2.7B | -37.44%622.01M | -35.57%1.24B | -28.81%139M | -12.51%3.17B | -30.41%994.26M |
| Operating profit | -0.86%10.78B | 31.12%7.43B | 29.37%6.15B | 36.83%1.99B | -25.00%10.87B | -43.12%5.67B | -46.76%4.75B | -46.44%1.45B | -27.87%14.49B | -30.77%9.97B |
| Financing income | ---- | -4.07%1.5B | ---- | -5.73%495.07M | ---- | 3.84%1.56B | ---- | 17.40%525.18M | ---- | -9.02%1.5B |
| Financing cost | 16.44%-650.68M | 17.25%-476.82M | 17.50%-332.48M | 9.21%-165.36M | 16.30%-778.71M | 1.43%-576.21M | 3.03%-403M | -7.58%-182.13M | -77.34%-930.4M | -71.48%-584.55M |
| Share of profits of associates | 52.31%358.46M | ---- | 21.07%184.79M | ---- | 31.64%235.35M | ---- | -23.08%152.63M | ---- | -55.60%178.79M | ---- |
| Share of profit from joint venture company | 342.32%291.04M | ---- | 109.59%99.92M | ---- | -46.19%65.8M | ---- | -55.81%47.67M | ---- | -53.40%122.27M | ---- |
| Special items of earning before tax | ---- | -57.94%173.01M | ---- | -27.55%150.35M | ---- | -10.84%411.33M | ---- | -50.92%207.54M | ---- | -7.35%461.35M |
| Earning before tax | 3.68%10.78B | 24.03%8.44B | 34.08%6.1B | 20.85%2.32B | -25.04%10.39B | -40.51%6.8B | -48.39%4.55B | -43.99%1.92B | -31.48%13.86B | -30.01%11.44B |
| Tax | -7.96%-2.55B | ---- | -43.63%-1.44B | ---- | 16.97%-2.37B | ---- | 40.82%-1B | ---- | 26.46%-2.85B | ---- |
| After-tax profit from continuing operations | 2.42%8.22B | 22.16%6.41B | 31.38%4.66B | 19.32%1.78B | -27.12%8.03B | -42.19%5.25B | -50.20%3.55B | -44.33%1.49B | -32.67%11.01B | -28.89%9.07B |
| Earning after tax | 2.42%8.22B | 22.16%6.41B | 31.38%4.66B | 19.32%1.78B | -27.12%8.03B | -42.19%5.25B | -50.20%3.55B | -44.33%1.49B | -32.67%11.01B | -28.89%9.07B |
| Minority profit | -858.03%-243.3M | 120.55%102.68M | -51.58%29.51M | -143.12%-35.1M | -107.76%-25.4M | -88.38%46.56M | -83.54%60.95M | -112.03%-14.44M | -34.09%327.43M | 18.00%400.67M |
| Profit attributable to shareholders | 5.12%8.46B | 21.28%6.3B | 32.83%4.63B | 20.51%1.81B | -24.65%8.05B | -40.05%5.2B | -48.37%3.49B | -41.14%1.5B | -32.62%10.69B | -30.17%8.67B |
| Basic earnings per share | 4.58%1.6 | 20.20%1.19 | 33.33%0.88 | 21.43%0.34 | -24.26%1.53 | -39.63%0.99 | -48.03%0.66 | -41.67%0.28 | -32.44%2.02 | -29.91%1.64 |
| Diluted earnings per share | 4.58%1.6 | 20.20%1.19 | 33.33%0.88 | 21.43%0.34 | -24.26%1.53 | -39.63%0.99 | -48.03%0.66 | -41.67%0.28 | -32.44%2.02 | -29.91%1.64 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.